ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tuya Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TUYA

NEW YORK, Sept. 04, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tuya Inc. (NYSE: TUYA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Tuya’s March 2021 initial public offering (the “IPO”) of the important October 11, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Tuya securities pursuant and/or traceable to the Registration Statement you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Tuya class action, go to https://rosenlegal.com/submit-form/?case_id=7007 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the IPO Registration Statement featured false and/or misleading statements and/or failed to disclose that: (1) a material portion of Tuya’s China-based customers were engaged in the widespread and systematic manipulation of reviews and product offerings in violation of Amazon.com’s terms of use; (2) prior to the IPO, a consumer investigation and data breach had exposed an illicit fake review scheme being perpetrated by many of Tuya’s clients, among others, which included, among other things, the exposure of 13 million records of organized fake review scams linked to over 200,000 Amazon account profiles; (3) as a result, there was a substantial risk that a material portion of Tuya’s significant customers would be barred from using Amazon.com’s platform, negatively impacting Tuya’s business, revenue, earnings, and prospects; and (4) as such, the IPO’s Registration Statement’s representations regarding Tuya’s historical financial and operational metrics and purported market opportunities and expected growth did not accurately reflect the actual business, operations, financial results, and trajectory of Tuya at the time of the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Tuya class action, go to https://rosenlegal.com/submit-form/?case_id=7007 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

HGEN INVESTOR ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – HGEN

NEW YORK, Sept. 04, 2022 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Humanigen, Inc. (NASDAQ: HGEN) between May 28, 2021 and July 12, 2022, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than October 25, 2022.

SO WHAT: If you purchased Humanigen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Humanigen class action, go to https://rosenlegal.com/submit-form/?case_id=8376 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 25, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business operations and prospects. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) lenzilumab was less effective in treating hospitalized COVID-19 patients than defendants had represented; (2) as a result, the U.S. Food and Drug Administration (“FDA”) was unlikely to approve the lenzilumab Emergency Use Authorization (“EUA”) and the ACTIV-5/BET-B study was unlikely to meet its primary endpoint; (3) accordingly, lenzilumab’s clinical and commercial prospects were overstated; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Humanigen class action, go to https://rosenlegal.com/submit-form/?case_id=8376 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

OM FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – OM

NEW YORK, Sept. 04, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between September 15, 2020 and June 13, 2022, both dates inclusive (the “Class Period”), of the important September 6, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Outset Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Outset Medical class action, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 6, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants had “continuously made improvements and updates to Tablo over time since its original clearance” that required an additional 510(k) application; (2) as a result, Outset Medical could not conduct a human factors study on a cleared device in accordance with FDA protocols; (3) Outset Medical’s inability to conduct the human factors study subjected Outset Medical to the likelihood of the FDA imposing a “shipment hold” and marketing suspension, leaving the Company unable to sell Tablo for home use; and (4) as a result, defendants’ positive statements about Outset Medical’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Outset Medical class action, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

‫Shanghai Electric تنجز المرحلة الثانية بقدرة 900 ميجاوات من مجمع محمد بن راشد آل مكتوم للطاقة الشمسية

شنغهاي, 4 شتنبر/أيلول 2022/PRNewswire/ –أعلنتShanghai Electric عن بدء تشغيل المرحلة ب من المرحلة الخامسة بقدرة 900 ميجاوات من مجمع محمد بن راشد آل مكتوم للطاقة الشمسية. كجزء من أكبر محطة للطاقة الكهروضوئية في العالم قيد الإنشاء، سيساعد المشروع في دفع دبي لترقية وتحويل مزيج الطاقة لديها من خلال توفير 2268 مليار كيلووات ساعة من إمدادات الطاقة سنويًا عند الانتهاء، وهو ما يكفي لخدمة أكثر من 240 ألف منزل وقادر على خفض 1.1 مليون طن من انبعاثات الكربون سنويًا.

Phase 5 of the Mohammed bin Rashid Al Maktoum Solar Park

“نحن فخورون جدًا برؤية مجمع الطاقة الشمسية وهو يحقق إنجازًا تاريخيًا آخر بعد توصيل المرحلة أ بالشبكة في عام 2021. قال منغ تشوانمين، مدير مشروع المرحلة الخامسة من مجمع محمد بن راشد آل مكتوم للطاقة الشمسية: “الآن، يجري العمل في المرحلة ج بشكل جيد ومن المتوقع أن تكتمل في عام 2023”.

“تتميز عملية بناء المرحلة الخامسة من مجمع محمد بن راشد آل مكتوم للطاقة الشمسية بسلسلة من التحديات، وبلغت ذروتها في ذروة جائحة كوفيد-19 التي عطلت بشدة سلاسل التوريد العالمية. وتغلب الفريق على الصعوبات وتأكد من تنفيذ عمليات شراء وتسليم المواد الخام للمشروع في الوقت المناسب لتجنب أي تأخير في التقدم الشامل “، أضاف منغ.

 لقد بذلت Shanghai Electric أيضًا جهودًا كبيرة للتحكم في التكاليف. مقارنة بفترة ما قبل الجائحة، أصبح شحن الحاويات غير متاح على نطاق واسع، حيث زادت أسعار نقل الكابلات بشكل عام بعشر مرات. لضمان إكمال المشروع في الموعد المحدد، قرر الفريق شحن الكابلات عبر ناقلات البضائع السائبة، على الرغم من أن الحل الجديد يزيد من عبء العمل.

بالإضافة إلى ذلك، نظرًا للحركة الطبيعية وسيولة الكثبان الرملية، اكتشف الفريق لاحقًا أن موقع البناء قد تم رفعه بمئات الآلاف من الأمتار المكعبة مقارنة بالقيمة التي تم مسحها سابقًا، مما أدى إلى إضافة 3 ملايين دولار إلى التكلفة الإجمالية. بعد إجراء تحقيق وبحث شامل، توصلت Shanghai Electric إلى خطة ساعدت الفريق في حل المشكلة مع ضمان عدم حدوث أي انقطاع في تقدم البناء.

قامت أكوا باور، المالك والمطور والمشغل للمرحلة الخامسة من مجمع محمد بن راشد للطاقة الشمسية، بتعيين Shanghai Electric كمقاول للهندسة والمشتريات والبناء ( EPC ) للمشروع في عام 2020. ابتداءً من يوليوز/تموز 2020، تألف المشروع من المراحل أ و ب و ج، بإجمالي قدرة مركبة تبلغ 1050 ميجاوات.

مع الفريق الدولي للمشروع الذي يوظف أكثر من 2500 عامل خلال فترة الذروة، تم الاعتراف بجهود Shanghai Electric لتوحيد أفضل القوى العاملة والموارد والإمدادات العالمية لبناء واحد من أكثر مجمعات الطاقة الشمسية تقدمًا في البلاد من قبل مالك المشروع و شركائه. بالإضافة إلى ذلك، خلق المشروع أيضًا أكثر من 4000 فرصة عمل مباشرة و 10000 فرصة عمل غير مباشرة، حيث لعب دورًا رئيسيًا في تعزيز العمالة المحلية والتنمية الاقتصادية.

كما شاركت Shanghai Electric في بناء المرحلة الرابعة من مجمع محمد بن راشد آل مكتوم للطاقة الشمسية بقدرة 950 ميجاوات، والتي تشمل محطة للطاقة الشمسية المركزة بقدرة 700 ميجاوات ( CSP ) ومحطة للطاقة الكهروضوئية بقدرة 250 ميجاوات ( PV ). إن الطاقة الشمسية المركزة ( CSP ) قادرة على تخزين الطاقة الحرارية خلال النهار، والتي يمكن استخدامها لاحقًا لتوليد الكهرباء في الليل، مما يوفر مصدر طاقة نظيفًا ومستقرًا وموثوقًا على مدار الساعة.

منذ بداية هذا المشروع في عام 2018، وظف أكثر من 8500 عامل خلال فترة الذروة، ومن المقرر توصيل محطة برج الطاقة الشمسية المركزة بطاقة 100 ميجاوات ومحطة الحوض المكافئ II بقدرة 200 ميجاوات بالشبكة في نهاية عام 2022. إنه يتميز بأحدث تقنيات الطاقة الشمسية في العالم والتي ستوفر طاقة نظيفة لنحو 320 ألف أسرة وتقلل 1.6 مليون طن من انبعاثات الكربون كل عام، وتقطع شوطًا طويلاً لمساعدة دبي على تحقيق رؤيتها المتجددة لعام 2050.

نبذة عن Shanghai Electric

مجموعة شنغهاي الكهربائية المحدودة  (SEHK: 2727, SSE: 601727) هي شركة مصنعة للمعدات الراقية على مستوى عالمي، وتركز على الطاقة الذكية والتصنيع الذكي والبنية التحتية الذكية لتوفير حلول أنظمة خضراء وذكية من الدرجة الصناعية. ولها وجود عالمي في صناعات مثل الطاقة الجديدة، والطاقة النظيفة الفعالة، والأتمتة الصناعية، والأجهزة الطبية، وحماية البيئة.

رابط الصورة https://mma.prnewswire.com/media/1890445/Phase_5_Mohammed_bin_Rashid_Al_Maktoum_Solar_Park.jpg

رابط الشعار:  https://mma.prnewswire.com/media/1800747/logo_new_Logo.jpg